TITLE

Genetic medicine: ethical and practical issues of application of the new technology

AUTHOR(S)
Kotalik, Jaro; Silverman, Melvin
PUB. DATE
February 2004
SOURCE
Clinical & Investigative Medicine;Feb2004, Vol. 27 Issue 1, p14
SOURCE TYPE
Academic Journal
DOC. TYPE
Proceeding
ABSTRACT
Discusses a symposium on ethical and practical issues on the application of technology in genetic medicine. Presentation by physician David Cole about ovarian cancer; Concern of Doctor Susan Sherwin about the difficulty in making accurate predictions of personal risk and the influence of the prevailing climate of fear of breast cancer; Arguments in favour of direct-to-direct consumer supply of genetic testing.
ACCESSION #
12485065

 

Related Articles

  • Ashkenazi community is not unwilling to participate in genetic research. Nelson, Nancy J.; Nelson, N J // JNCI: Journal of the National Cancer Institute;06/17/98, Vol. 90 Issue 12, p884 

    Presents information on the Jewish Leadership Meeting on Genetics which was held in Washington, D.C., during April, 1998, which discussed the participation of Jewish women in breast cancer research. Indication that reports had portrayed the women as unwilling to participate in the research; Who...

  • PIK3CA gene signature predicted improved clinical outcome in breast cancer. Haigh, Christen // Hem/Onc Today;6/10/2009, Vol. 10 Issue 11, p23 

    The article focuses on a study which revealed that PIK3CA gene signature predicted improved clinical outcome in breast cancer, presented at the 2009 IMPAKT Breast Cancer Conference in Brussels, Belgium on May 7-9.

  • Five Moffitt Cancer Center Experts Share Latest Advances in Breast Cancer Treatment -- Go to moffitcancernetwork.org.  // Ascribe Newswire: Medicine;8/9/2002, p5 

    This article presents information on H. Lee Moffitt Cancer Center & Research Institute's Breast Health Symposium on July 12, 2002, the presentation of which is available on web at http://moffittcancernetwork.org. Genetic screening, radioactive seed breast biopsy and fatigue during chemotherapy...

  • BRCA testing: ethics lessons for the new genetics. Sherwin, Susan // Clinical & Investigative Medicine;Feb2004, Vol. 27 Issue 1, p19 

    Focuses on ethical lessons on breast cancer (BRCA) testing. Benefits of the development of tests for genetic susceptability to particular disease; Importance of taking BRCA test; Factors making it difficult for patients and medical experts to determine morally appropriate responses to the...

  • Breast Cancer Conference to convene tomorrow.  // Caribbean Business;10/11/2001, Vol. 29 Issue 41, p61 

    Highlights the convention of Annual Breast Cancer Conference in Ritz Carlton San Juan Hotel in Puerto Rico. Inclusion of 14 medical experts in the field of breast cancer; Names of the speakers; Topics to be discussed.

  • Notes from the 8th St. Gallen International Consensus Conference on Primary Therapy of Early Breast Cancer.  // Turkish Journal of Cancer;Jan2003, Vol. 33 Issue 1, p55 

    Talks about the St. Gallen International Consensus Conference on primary therapy of early breast cancer that was held in Switzerland in 2003. Participants; Information on the speech given by Nancy Davidson, a physician from the U.S., on endocrine treatments; Issues that were discussed at the...

  • Treating secondary causes of osteoporosis reduced further bone loss in women with breast cancer.  // Endocrine Today;Jun20092009, Vol. 7 Issue 8, p6 

    The article presents an overview of a study on treating secondary causes of osteoporosis in women with breast cancer, as discussed at the American Association of Clinical Endocrinologists 18th Annual Meeting & Clinical Congress held in Houston, Texas in May 2009.

  • 4th IMPAKT Breast Cancer Conference: Annals of Oncology: Breast cancer in young women: A distinct disease.  // Biomedical Market Newsletter;5/7/2012, Vol. 21, p1 

    The article offers information on the 4th IMPAKT Breast Cancer Conference that was held in Brussels, Belgium in which the researchers reported that breast cancer is a biologically unique disease which require customized management strategies.

  • Ethical, Social and Economic Issues in Familial Breast Cancer: a compilation of views from the E.C. Biomed II Demonstration Project. Steel, Michael; Smyth, Elizabeth; Vasen, Hans; Eccles, Diana; Evans, Gareth; Møller, Pål; Hodgson, Shirley; Stoppa-Lyonnet, Dominique; Chang-Claude, Jenny; Caligo, Maria; Morrison, Patrick; Haites, Neva // Disease Markers;1999, Vol. 15 Issue 1/3, p125 

    Demand for clinical services for familial breast cancer is continuing to rise across Europe.  Service provision is far from uniform and, in most centres, its evolution has been determined by local conditions, specifically by local research interests, rather than by central...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics